Correlation Between Protalix Biotherapeutics and Ardelyx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Protalix Biotherapeutics and Ardelyx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protalix Biotherapeutics and Ardelyx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protalix Biotherapeutics and Ardelyx, you can compare the effects of market volatilities on Protalix Biotherapeutics and Ardelyx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protalix Biotherapeutics with a short position of Ardelyx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protalix Biotherapeutics and Ardelyx.

Diversification Opportunities for Protalix Biotherapeutics and Ardelyx

-0.59
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Protalix and Ardelyx is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Protalix Biotherapeutics and Ardelyx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ardelyx and Protalix Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protalix Biotherapeutics are associated (or correlated) with Ardelyx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ardelyx has no effect on the direction of Protalix Biotherapeutics i.e., Protalix Biotherapeutics and Ardelyx go up and down completely randomly.

Pair Corralation between Protalix Biotherapeutics and Ardelyx

Considering the 90-day investment horizon Protalix Biotherapeutics is expected to generate 46.52 times less return on investment than Ardelyx. But when comparing it to its historical volatility, Protalix Biotherapeutics is 1.24 times less risky than Ardelyx. It trades about 0.0 of its potential returns per unit of risk. Ardelyx is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  399.00  in Ardelyx on September 2, 2024 and sell it today you would earn a total of  168.00  from holding Ardelyx or generate 42.11% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Protalix Biotherapeutics  vs.  Ardelyx

 Performance 
       Timeline  
Protalix Biotherapeutics 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Protalix Biotherapeutics are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain essential indicators, Protalix Biotherapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Ardelyx 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Ardelyx are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Ardelyx may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Protalix Biotherapeutics and Ardelyx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Protalix Biotherapeutics and Ardelyx

The main advantage of trading using opposite Protalix Biotherapeutics and Ardelyx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protalix Biotherapeutics position performs unexpectedly, Ardelyx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ardelyx will offset losses from the drop in Ardelyx's long position.
The idea behind Protalix Biotherapeutics and Ardelyx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals